Home » Topics » Regulatory » Patents

Patents
RSS

Taiho Pharmaceutical discloses androgen receptor antagonists

June 16, 2017

GVK Biosciences patents PI3Kbeta inhibitors

June 16, 2017

Novartis discloses Janus kinase inhibitors

June 15, 2017

Chiesi Farmaceutici discloses muscarinic M3 receptor antagonists and beta2-adrenoceptor agonists

June 15, 2017

Cancer Research Technology and AstraZeneca divulge GLS inhibitors

June 15, 2017

Adaptimmune and Immunocore identify TRPM1 derivatives

June 15, 2017

Leids Universitair Medisch Centrum presents recombinant serine protease variants

June 15, 2017

Genentech and Xenon Pharmaceuticals disclose Nav1.7 channel blockers

June 14, 2017

Ohara Pharmaceutical discloses prodrugs of azacytidine and decitabine

June 14, 2017

AbbVie discovers 5-HT2C receptor agonists

June 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...